News & Insights

Gide advised Veolia Environnement on its €400 million non-dilutive cash-settled convertible bonds issuance, maturing in 2032.The bonds bear interest a...

Gide advised Inventiva, a biopharmaceutical company listed on Euronext Paris and the NASDAQ Global Market, specializing in the development of oral the...

Gide advised the bank syndicate composed of J.P. Morgan, Crédit Agricole CIB, BNP PARIBAS and Société Générale Corporate & Investment Banking in c...

Gide advised Eurazeo in connection with its inaugural issue of senior notes for an aggregate principal amount of €500 million with a 4.625% fixed coup...

Gide has advised the banking syndicate composed of Leerink Partners, Stifel and Baird on the €60 million financing by Sensorion, including a €20 milli...

Gide assisted Groupama Assurances Mutuelles on its subordinated Restricted Tier 1 perpetual notes issuance for a total amount of €600 million, with an...

Inventiva is a clinical-stage biopharmaceutical company focused on the development of oral therapies for the treatment of metabolic dysfunction-associ...

Gide advised a bank syndicate composed of Barclays Bank Ireland PLC, Crédit Agricole Corporate and Investment Bank, Mediobanca – Banca di Credito Fina...

Gide advises the European Investment Bank (EIB) on a €37.5 million venture debt financing for MaaT Pharma, a French biotechnology company listed on Eu...

Gide advised the bank syndicate composed of BNP Paribas, Citigroup Global Markets Europe AG, Commerzbank Aktiengesellschaft, Crédit Agricole Corporate...